Did CDSCO Labs Identify 211 Drug Samples as ‘Not of Standard Quality’ in October?
Click to start listening
Synopsis
In a recent announcement, the CDSCO highlighted serious concerns by declaring 211 drug samples as ‘Not of Standard Quality’ in October. This alarming figure raises questions about the quality control measures in place and their implications on public health. Read on to understand the details of this significant finding.
Key Takeaways
- 211 drug samples declared NSQ by CDSCO in October.
- Central and State Laboratories involved in the identification.
- Regular monitoring in collaboration with state regulators.
- NSQ designation based on failure in quality parameters.
- Counterfeit drugs reported from Bihar and Delhi.
New Delhi, Nov 21 (NationPress) The Central Drugs Standard Control Organisation (CDSCO) announced on Friday that a total of 211 drug samples assessed by both central and state drug regulatory bodies were classified as ‘Not of Standard Quality (NSQ)’ in the monthly drug alert for October.
Out of these, the Central Drugs Laboratories flagged 63 samples as NSQ, while the State Drugs Testing Laboratories identified 148 samples with the same designation.
In line with its routine regulatory oversight, the CDSCO updates the list of NSQ and counterfeit drugs on its portal each month.
“For October 2025, Central Drugs Laboratories confirmed 63 drug samples as Not of Standard Quality (NSQ), alongside 148 samples recognized as NSQ by State Drugs Testing Laboratories,” the alert stated.
The designation of a drug sample as NSQ arises when it fails to meet one or more specified quality standards.
This failure is specific to the batch tested by government laboratories and should not raise alarms regarding other available drug products, as per health officials.
Moreover, during October, “three drug samples from Bihar and two from Delhi were confirmed as counterfeit, produced by unauthorized manufacturers using the brand names of legitimate companies,” they added. Investigations are ongoing and actions will be pursued according to the relevant laws.
The identification of NSQ and counterfeit medicines occurs regularly in collaboration with state regulators to ensure the removal of these products from the market.
The preparation of the NSQ list involves active participation from various regulators at both central and state levels, showcasing the strength of the regulatory framework aimed at enhancing the quality of public health medicines.
In September, the CDSCO reported that 112 drug samples had been tested as NSQ by the Central and state drug regulatory authorities.
The Central Drugs Laboratories categorized 52 samples as NSQ, while the State Drugs Testing Laboratories marked 60 samples similarly.
Point of View
It's imperative to recognize the CDSCO's proactive measures in identifying substandard drugs. The continuous monitoring and regulation of drug quality are vital for safeguarding public health. This initiative reflects a commitment to maintaining high standards and ensuring that the public is aware of potential health risks associated with NSQ drugs.
NationPress
21/11/2025
Frequently Asked Questions
What does NSQ stand for?
NSQ stands for 'Not of Standard Quality', indicating that a drug sample has failed to meet specified quality standards.
How many drug samples were flagged in October?
In October, a total of 211 drug samples were flagged as NSQ by the CDSCO.
What actions are taken against NSQ drugs?
The CDSCO collaborates with state regulators to identify and remove NSQ drugs from the market, ensuring public safety.
Are all drug products in the market unsafe?
No, the identification of NSQ drugs is specific to the tested batches and does not imply that all drugs available in the market are unsafe.
What regions were affected by the counterfeit drug samples?
Counterfeit drug samples were identified from Bihar and Delhi.
